Cargando…

Smart watch-based coaching with tiotropium and olodaterol ameliorates physical activity in patients with chronic obstructive pulmonary disease

Combined therapy with tiotropium and olodaterol notably improves parameters of lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD) compared to mono-components; however, its effect on physical activity is unknown. The present study evaluated whether combina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hataji, Osamu, Nishii, Yoichi, Ito, Kentaro, Sakaguchi, Tadashi, Saiki, Haruko, Suzuki, Yuta, D'Alessandro-Gabazza, Corina, Fujimoto, Hajime, Kobayashi, Tetsu, Gabazza, Esteban C., Taguchi, Osamu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658686/ https://www.ncbi.nlm.nih.gov/pubmed/29104624 http://dx.doi.org/10.3892/etm.2017.5088

Ejemplares similares

Comparable immunoreactivity rates of PD‐L1 in archival and recent specimens from non‐small cell lung cancer
por: Nakamura, Yuki, et al.
Publicado: (2018)

Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report
por: Nishii, Yoichi, et al.
Publicado: (2022)

Factors leading to failure to diagnose pulmonary malignant tumors using endobronchial ultrasound with guide sheath within the target lesion
por: Nishii, Yoichi, et al.
Publicado: (2019)

Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kobayashi, Tetsu, et al.
Publicado: (2020)

Use of Ultrathin Bronchoscope on a Need Basis Improves Diagnostic Yield of Difficult-to-Approach Pulmonary Lesions
por: Nishii, Yoichi, et al.
Publicado: (2020)

Efficacy of osimertinib in a patient with non-small cell lung cancer harboring epithelial growth factor receptor exon 19 deletion/T790M mutation, with poor performance status
por: Nishii, Yoichi, et al.
Publicado: (2018)

The Potential of Digital Polymerase Chain Reaction for Improving Diagnostic Yield of Nontuberculous Mycobacteria Pulmonary Disease
por: Nishii, Yoichi, et al.
Publicado: (2021)

Renal Injury during Long-Term Crizotinib Therapy
por: Yasuma, Taro, et al.
Publicado: (2018)

Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions
por: Nishii, Yoichi, et al.
Publicado: (2023)

No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness
por: Yasuma, Taro, et al.
Publicado: (2021)

A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer
por: Fujiwara, Atsushi, et al.
Publicado: (2018)

Identification of Halophilic Microbes in Lung Fibrotic Tissue by Oligotyping
por: D’Alessandro-Gabazza, Corina N., et al.
Publicado: (2018)

A Case of Hemoptysis Due to Bronchial Varices Treated with Variceal Sclerotherapy
por: Sakaguchi, Tadashi, et al.
Publicado: (2020)

Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions
por: Yasuma, Taro, et al.
Publicado: (2021)

The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022)

Microbial Burden-associated Cytokine Storm May Explain Nonresolving Acute Respiratory Distress Syndrome in Patients with COVID-19
por: Yasuma, Taro, et al.
Publicado: (2022)

Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
por: Yasuma, Taro, et al.
Publicado: (2022)

De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung Adenocarcinoma
por: Fujiwara, Takumi, et al.
Publicado: (2020)

Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy
por: Nishimura, Tadashi, et al.
Publicado: (2022)

Protein S is Protective in Acute Lung Injury by Inhibiting Cell Apoptosis
por: Baffour Tonto, Prince, et al.
Publicado: (2019)

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease
por: Hataji, Osamu, et al.
Publicado: (2013)

Correction to: Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)

Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection
por: Kogue, Yurie, et al.
Publicado: (2023)

A Prediction Equation to Assess Resting Energy Expenditure in Japanese Patients with COPD
por: Morikawa, Keisuke, et al.
Publicado: (2020)

Physical Activity Estimated by the Wearable Device in Lung Disease Patients: Exploratory Analyses of Prospective Observational Study
por: Ito, Kentaro, et al.
Publicado: (2023)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
por: Derom, Eric, et al.
Publicado: (2016)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
por: Ichinose, Masakazu, et al.
Publicado: (2018)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
por: Lan, Ying, et al.
Publicado: (2023)

Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non‐small cell lung cancer
por: Sakaguchi, Tadashi, et al.
Publicado: (2020)

A method to improve genetic analysis of lung cancer samples
por: Sakaguchi, Tadashi, et al.
Publicado: (2021)

Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma
por: Takahashi, Yoshinori, et al.
Publicado: (2019)

Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
por: Maruyama, Takaya, et al.
Publicado: (2010)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
por: Pelaia, Girolamo, et al.
Publicado: (2015)

Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
por: Tamura, Tomohiro, et al.
Publicado: (2016)

Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung Fibrosis
por: Okano, Tomohito, et al.
Publicado: (2020)

A Microbiome-Derived Peptide Induces Apoptosis of Cells from Different Tissues
por: Saiki, Haruko, et al.
Publicado: (2021)

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD
por: Maltais, François, et al.
Publicado: (2019)

Three-dimensional computed tomography angiography for the preoperative evaluation of coronary artery disease in lung cancer patients
por: Watanabe, Fumiaki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s84ctqp7btf24qdla2i24h4mji